Search
Search Results
##search.searchResults.foundPlural##
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2329PDF: 1862HTML: 896 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9376PDF: 6240HTML: 88126Fig.1b: 241Fig.1c: 242Fig.2a: 227Fig.2b: 220Fig.4: 246Fig.2c: 221Fig.3: 225Tab.1: 282Tab.2: 261Tab.3: 240Tab.4: 274Fig1a: 235 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
3008PDF: 1337HTML: 2836Figure 1: 212 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1954PDF: 870HTML: 10360Figures 1,2,3: 239 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
3090PDF: 918HTML: 6618Untitled: 275Untitled: 232Untitled: 244Untitled: 259 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
3016PDF: 1065HTML: 5653 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4621PDF: 3806HTML: 376 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4396PDF: 2000HTML: 5520Table 1: 246 -
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
3304PDF: 1160HTML: 1938 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2083PDF: 796HTML: 725Table1: patient's characteristics: 190Table 2: profile of each patient: 211 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3819PDF: 952HTML: 6882 -
POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.
1208PDF: 635Suppl. Files: 149HTML: 504 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3613PDF: 937HTML: 1695figure 1: 198Untitled: 222 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1837PDF: 1243HTML: 350 -
A STUDY ON THE EXPRESSION OF BCR-ABL TRANSCRIPT IN MIXED PHENOTYPE ACUTE LEUKEMIA (MPAL) CASES USING THE REVERSE TRANSCRIPTASE POLYMERASE REACTION ASSAY (RT-PCR) AND ITS CORRELATION WITH HEMATOLOGICAL REMISSION STATUS POST INITIAL INDUCTION THERAPY
1449PDF: 895HTML: 5086INSTITUTE PUBLICATION COMMITTEE APPROVAL: 196 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3431PDF: 1009HTML: 3004 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2339PDF: 870HTML: 1703Figure 1: 241Table 1: 250 -
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS
1623PDF: 953HTML: 2012Figure: 206Tables: 219ALL revision 1: 299response to reviewer: 212 -
ASSOCIATION OF BASELINE PLATELET COUNT WITH COMPLETE REMISSION, SEVERE BLEEDING, AND 24-MONTH OVERALL SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: A SINGLE-CENTER RETROSPECTIVE COHORT STUDY
106PDF: 82Suppl. Files: 17Html: 16Html Suppl. Files: 15 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
2143PDF: 880HTML: 262 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3936PDF: 1744HTML: 11880Figures Haase: 249 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1598HTML: 680PDF: 897 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2585PDF: 836HTML: 1748 -
ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS Anorectal pathologies in leukemias
1278PDF: 784Html: 120 -
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience. Coagulopathy in APL treated with ATRA and Arsenic Trioxide.
1219PDF: 1156HTML: 504 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2589PDF: 1245HTML: 1085 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4519PDF: 1810HTML: 1126







